LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Search

Insulet Corp

Suletud

Sektor Tervishoid

214.53 -0.5

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

213.84

Max

215.63

Põhinäitajad

By Trading Economics

Sissetulek

137M

189M

Müük

47M

489M

P/E

Sektori keskmine

60.6

103.001

Aktsiakasum

0.55

Kasumimarginaal

38.608

Töötajad

3,000

EBITDA

-3.1M

81M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+10.73 upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

31. okt 2024

Turustatistika

By TradingEconomics

Turukapital

14B

Eelmine avamishind

215.03

Eelmine sulgemishind

214.53

Uudiste sentiment

By Acuity

50%

50%

114 / 365 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

Insulet Corp Graafik

Seotud uudised

3. okt 2023, 20:53 UTC

Omandamised, ülevõtmised, äriostud

Insulet CFO McMillan Steps Down to Join 3M Health Care Business

30. nov 2023, 17:43 UTC

Tulu

Salesforce, Insulet, and Datadog Are November's Top Performers -- and These Are the Worst -- Barrons.com

17. nov 2023, 12:00 UTC

Peamised uudised

Obesity Drugs Put These Stocks on a Crash Diet, and Now They're Rebounding -- Heard on the Street -- WSJ

Võrdlus sarnastega

Hinnamuutus

Insulet Corp Prognoos

Hinnasiht

By TipRanks

10.73% tõus

12 kuu keskmine prognoos

Keskmine 237.79 USD  10.73%

Kõrge 264 USD

Madal 185 USD

Põhineb 14 Wall Streeti analüütiku instrumendi Insulet Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

14 ratings

11

Osta

3

Hoia

0

Müü

Tehniline skoor

By Trading Central

204.42 / 216.11Toetus ja vastupanu

Lühikene perspektiiv

Strong Bullish Evidence

Keskpikk perspektiiv

Very Strong Bullish Evidence

Pikk perspektiiv

Bullish Evidence

Sentiment

By Acuity

114 / 365 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Insulet Corp

Insulet Corporation is primarily engaged in the development, manufacture and sale of its proprietary Omnipod System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod Insulin Management System (Omnipod), the Omnipod DASHTM Insulin Management System (Omnipod DASH) and its digital mobile Omnipod platform. The Omnipod System features two devices: a small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod) and a Personal Diabetes Manager (PDM). Users has to fill the Pod with insulin and wear directly on the body. It can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh or lower back. The Pod delivers precise, personalized doses of insulin into the body through a small flexible tube, cannula. PDM is a wireless, handheld device that programs the Pod with the user’s personalized insulin-delivery instructions and wirelessly monitors the Pod’s operation.